Complex Litigation Blog - Recent Legal News

View updates for:
Published: December 7th, 2016
A federal jury has ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion in compensatory and punitive damages to six plaintiffs who sustained debilitating injuries purportedly associated with a metal-on-metal version of the Pinnacle Hip Replacement System. In doin...Read More
Published: November 29th, 2016
Plaintiffs around the country continue to file Xarelto lawsuits over the serious side effects allegedly associated with the blood-thinning medication. According to an update issued by the U.S. Judicial Panel on Multidistrict Litigation on November 15th, there are now 13,727 cases pending in a centra...Read More
Published: November 22nd, 2016
Another Risperdal gynecomastia lawsuit settled last month in Pennsylvania, just before the case was scheduled to go to trial in the Philadelphia Court of Common Pleas. Terms of this most recent settlement remain confidential, and neither Johnson & Johnson nor its Janssen Pharmaceuticals unit hav...Read More
Published: November 14th, 2016
Discovery will soon get underway in the federal Zofran birth defects litigation. According to a Scheduling Order issued on November 10th in the U.S. District Court, District of Massachusetts, that process will encompass five distinct phases. Zofran Discovery Phases Discovery is the formal investig...Read More
Published: November 7th, 2016
Wright Medical Technologies, Inc. has agreed to settle hundreds of hip replacement lawsuits for $240 million, including those involving its metal-on-metal Conserve hip line. According to a statement issued by the company, 95% of those eligible for the proposed Wright hip settlement must agree to its...Read More
Published: October 31st, 2016
A Pennsylvania mass tort litigation that involves more than 1,000 Xarelto lawsuits has adopted a plan for the selection of bellwether trial cases. According to a report from The Legal Intelligencer, the Xarelto program could become the first mass tort in the Philadelphia Complex Litigation Center to...Read More
Published: October 20th, 2016
October 20, 2016 Bernstein Liebhard LLP is honored to announce that the firm has been recognized by The National Law Journal as one of a select group of “America’s Elite Trial Lawyers” for the third consecutive year.  The firm was selected for its creative and significant work on behalf of...Read More
Published: October 19th, 2016
GlaxoSmithKline has asked a federal court to dismiss fraud claims put forth in hundreds of Zofran birth defects lawsuits now pending in a multidistrict litigation underway in the U.S. District Court, District of Massachusetts. According to, the company asserts that the suits fail to suffi...Read More
Published: October 11th, 2016
The Levaquin attorneys at Bernstein Liebhard LLP continue to actively pursue legal claims involving the side effects allegedly associated with the use of fluoroquinolone antibiotics. The Firm’s most recent case was filed in late September, on behalf of a Pennsylvania man who experienced an aortic ...Read More
Published: October 7th, 2016
October 7, 2016 Bernstein Liebhard LLP is pleased to announce that seven of the Firm’s attorneys have been named by Super Lawyers to be among the top lawyers in New York State.  Super Lawyers ranks outstanding lawyers who have attained a high degree of peer recognition and professional ac...Read More